股本结构
单位：万股
| 公告日期 | 2026-08-13 | 2026-08-13 | 2026-05-06 | 2026-05-06 | 2026-03-26 | 2025-12-22 |
|---|---|---|---|---|---|---|
| 证券总股本 | 808.75 | 757.72 | 639.86 | 585.57 | 388.78 | 384.30 |
| 普通股本 | 808.75 | 757.72 | 639.86 | 585.57 | 388.78 | 384.30 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-08-13 | 2026-06-30 | 2026-05-06 | 2026-03-31 | 2025-12-31 | 2025-12-17 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-08-13 | 808.75 | 未披露 | 定期报告 | 2026-08-13 |
| 2026-08-13 | 757.72 | 未披露 | 定期报告 | 2026-06-30 |
| 2026-05-06 | 639.86 | 未披露 | 定期报告 | 2026-05-06 |
| 2026-05-06 | 585.57 | 未披露 | 定期报告 | 2026-03-31 |
| 2026-03-26 | 388.78 | 未披露 |
更多>>
From December 31, 2024 to December 31, 2025
Shares issued - convertible debentures
Exercise of options
Exercise of warrants
Exercise of RSUs
Shares issued for debt
Shares issued
|
2025-12-31 |
| 2025-12-22 | 384.30 | 未披露 | 定期报告 | 2025-12-17 |
| 2025-12-11 | 383.46 | 未披露 |
更多>>
Class B Subordinate Voting Shares offered 17,626 shares by the company
|
2025-12-10 |
| 2025-10-31 | 381.70 | 未披露 | 定期报告 | 2025-10-29 |
| 2025-12-22 | 381.69 | 未披露 | 定期报告 | 2025-09-30 |
| 2025-08-07 | 381.58 | 未披露 | 定期报告 | 2025-08-06 |
| 2025-08-07 | 346.87 | 未披露 | 定期报告 | 2025-06-30 |
| 2025-05-14 | 290.76 | 未披露 | 定期报告 | 2025-05-14 |
| 2025-05-14 | 271.11 | 未披露 |
更多>>
From December 31, 2024 to March 31, 2025
Shares issued - convertible debt
Exercise of options
|
2025-03-31 |
| 2025-03-28 | 229.95 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Shares issued
Shares for debt
RSU converted to shares
|
2024-12-31 |
| 2024-11-12 | 186.42 | 未披露 |
更多>>
From December 31, 2023 to September 30, 2024
Shares issued
Shares for debt
Share options exercised
RSU converted to shares
|
2024-09-30 |
| 2024-08-15 | 130.07 | 未披露 |
更多>>
FSD Pharma Inc. is pleased to announce the proposed consolidation of its issued and outstanding class A multiple voting shares and class B subordinate voting shares of the Company on the basis of one post-consolidation Class A Multiple Voting Share and Class B Subordinate Voting Share for every sixty-five pre-consolidation Class A Multiple Voting Shares and Class B Subordinate Voting Shares.
|
2024-08-15 |
| 2024-08-14 | 8453.12 | 未披露 | 定期报告 | 2024-08-13 |
| 2024-08-12 | 7764.94 | 未披露 | 定期报告 | 2024-08-09 |
| 2024-08-14 | 4740.85 | 未披露 | 定期报告 | 2024-06-30 |
| 2024-07-08 | 4500.97 | 未披露 | 定期报告 | 2024-06-12 |
| 2024-05-15 | 4210.29 | 未披露 | 定期报告 | 2024-05-14 |
| 2024-04-02 | 4042.96 | 未披露 | 定期报告 | 2024-03-28 |
| 2023-12-26 | 3937.68 | 未披露 | 定期报告 | 2023-12-26 |
| 2023-12-21 | 3937.68 | 未披露 | 定期报告 | 2023-12-21 |
| 2023-12-15 | 3937.68 | 未披露 | 定期报告 | 2023-12-04 |
| 2023-11-15 | 3935.89 | 未披露 | 定期报告 | 2023-09-30 |
| 2023-05-15 | 3904.07 | 未披露 | 定期报告 | 2023-05-15 |
| 2023-05-15 | 3902.87 | 未披露 | 定期报告 | 2023-03-31 |
| 2023-03-31 | 4064.38 | 未披露 | 定期报告 | 2023-03-30 |
| 2023-03-31 | 3850.43 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Share repurchase
Share-based payments
Share cancellation
Warrants expired
PSUs converted to shares
|
2022-12-31 |
| 2022-11-14 | 3810.43 | 未披露 | 定期报告 | 2022-11-11 |
| 2022-11-14 | 3811.43 | 未披露 |
更多>>
From December 31, 2021 to September 30, 2022
Share repurchase
Shares-based payments
Share cancellation
|
2022-09-30 |
| 2022-08-12 | 3821.82 | 未披露 | 定期报告 | 2022-08-12 |
| 2022-08-12 | 3840.72 | 未披露 |
更多>>
From December 31, 2021 to June 30, 2022
Share repurchase
Shares-based payments
Share cancellation
|
2022-06-30 |
| 2022-05-23 | 3852.52 | 未披露 | 定期报告 | 2022-05-19 |
| 2022-05-13 | 3850.48 | 未披露 | 定期报告 | 2022-05-13 |
| 2022-03-31 | 4045.08 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Shares issued
Share-based payments
Share cancelation
Lucid acquisition
|
2021-12-31 |
| 2021-11-15 | 4042.40 | 未披露 | 定期报告 | 2021-11-12 |
| 2021-11-15 | 4041.06 | 未披露 |
更多>>
From December 31, 2020 to September 30, 2021
Shares issued
Share-based payments
Share cancelation
Lucid acquisition
|
2021-09-30 |
| 2021-09-21 | 4055.79 | 未披露 | 定期报告 | 2021-09-13 |
| 2021-08-13 | 3583.56 | 未披露 |
更多>>
From December 31, 2020 to June 30, 2021
Shares issued
Share-based payments
Share cancellation
|
2021-06-30 |
| 2021-05-07 | 3599.19 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Shares issued
Share-based payments
|
2021-03-31 |
| 2021-03-17 | 3511.51 | 未披露 | 定期报告 | 2021-03-16 |
| 2021-02-11 | 2651.80 | 未披露 | 定期报告 | 2021-02-10 |
| 2021-01-27 | 1916.17 | 未披露 | 定期报告 | 2021-01-26 |
| 2021-03-17 | 1916.17 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Shares issued
Share-based payments
Share options exercised
|
2020-12-31 |
| 2020-11-16 | 1484.35 | 未披露 |
更多>>
from December 31, 2019 to September 30, 2020
Shares issued
Share-based payments
Share options exercised
|
2020-09-30 |
| 2020-08-11 | 1021.98 | 未披露 |
更多>>
from December 31, 2019 to June 30, 2020
Shares issued
Share-based payments
Share options exercised
|
2020-06-30 |
| 2020-07-13 | 1019.75 | 未披露 |
更多>>
The Corporation announced that it entered into definitive agreements with certain institutional investors pertaining to the private placement (the "Private Placement") by certain placement agents led by A.G.P./Alliance Global Partners (collectively, the "Placement Agents") of an aggregate of 1,500,000 Class B Shares at a price of C$6.75 per Class B Share. The Private Placement was completed on June 8, 2020.
|
2020-06-08 |
| 2020-05-15 | 869.75 | 未披露 | 定期报告 | 2020-05-14 |
| 2020-05-15 | 863.37 | 未披露 |
更多>>
from December 31, 2019 to March 31, 2020
Shares issued
Share-based payments
|
2020-03-31 |
| 2020-03-04 | 815.88 | 未披露 | 定期报告 | 2020-03-03 |
| 2020-03-04 | 790.58 | 未披露 |
更多>>
from December 31, 2018 to January 9, 2020
Shares issued
Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc.
Share options exercised
Warrants exercised
|
2020-01-09 |
From December 31, 2024 to December 31, 2025
Shares issued - convertible debentures
Exercise of options
Exercise of warrants
Exercise of RSUs
Shares issued for debt
Shares issued
Class B Subordinate Voting Shares offered 17,626 shares by the company
From December 31, 2024 to March 31, 2025
Shares issued - convertible debt
Exercise of options
From December 31, 2023 to December 31, 2024
Shares issued
Shares for debt
RSU converted to shares
From December 31, 2023 to September 30, 2024
Shares issued
Shares for debt
Share options exercised
RSU converted to shares
FSD Pharma Inc. is pleased to announce the proposed consolidation of its issued and outstanding class A multiple voting shares and class B subordinate voting shares of the Company on the basis of one post-consolidation Class A Multiple Voting Share and Class B Subordinate Voting Share for every sixty-five pre-consolidation Class A Multiple Voting Shares and Class B Subordinate Voting Shares.
From December 31, 2021 to December 31, 2022
Share repurchase
Share-based payments
Share cancellation
Warrants expired
PSUs converted to shares
From December 31, 2021 to September 30, 2022
Share repurchase
Shares-based payments
Share cancellation
From December 31, 2021 to June 30, 2022
Share repurchase
Shares-based payments
Share cancellation
From December 31, 2020 to December 31, 2021
Shares issued
Share-based payments
Share cancelation
Lucid acquisition
From December 31, 2020 to September 30, 2021
Shares issued
Share-based payments
Share cancelation
Lucid acquisition
From December 31, 2020 to June 30, 2021
Shares issued
Share-based payments
Share cancellation
From December 31, 2020 to March 31, 2021
Shares issued
Share-based payments
From December 31, 2019 to December 31, 2020
Shares issued
Share-based payments
Share options exercised
from December 31, 2019 to September 30, 2020
Shares issued
Share-based payments
Share options exercised
from December 31, 2019 to June 30, 2020
Shares issued
Share-based payments
Share options exercised
The Corporation announced that it entered into definitive agreements with certain institutional investors pertaining to the private placement (the "Private Placement") by certain placement agents led by A.G.P./Alliance Global Partners (collectively, the "Placement Agents") of an aggregate of 1,500,000 Class B Shares at a price of C$6.75 per Class B Share. The Private Placement was completed on June 8, 2020.
from December 31, 2019 to March 31, 2020
Shares issued
Share-based payments
from December 31, 2018 to January 9, 2020
Shares issued
Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc.
Share options exercised
Warrants exercised